Consolidated Statements of Income

(Five-Year Summary)

(Millions of Yen)

2022/03

2023/03

2024/03

2025/03

2026/03

Sales to customer

300,918

350,665

339,372

362,693

394,316

Cost of sales

187,376

230,723

225,438

243,045

266,620

Gross profit

113,541

119,941

113,933

119,647

127,696

SG&A expenses

70,187

81,996

91,691

99,050

110,619

Operating income

43,354

37,945

22,242

20,597

17,076

Non-operating income

1,492

1,678

2,161

2,977

2,400

  Interest and Dividends income

767

1,066

1,405

1,928

1,593

Non-operating expenses

1,615

917

1,066

1,394

2,615

  Interest and discounts expenses

330

324

450

700

1,517

Ordinary income

43,230

38,706

23,336

22,180

16,861

Extraordinary gain

4,658

1,681

4,034

4,734

7,392

Extraordinary loss

6,928

694

1,132

1,099

5,983

Income before income taxes and minority interests

40,961

39,692

26,238

25,815

18,270

Current income taxes

11,900

10,144

8,899

8,417

10,148

Deferred income taxes

▲309

857

▲426

75

▲356

Net income

29,370

28,690

17,766

17,322

8,478

Net income attributable to the noncontrolling interest

8,601

7,483

1,589

1,120

▲3,217

Net income attributable to owners of the parent

20,769

21,206

16,176

16,202

11,696

Main Consolidated Financial Summary

(Millions of Yen)

2022/03

2023/03

2024/03

2025/03

2026/03

Total Current assets

232,323

241,513

245,213

245,433

249,314

Fixed assets

130,114

157,661

192,254

232,154

264,486

Total current liabilities

79,151

67,454

80,657

73,419

82,037

Total long-term liabilities

58,730

76,401

76,345

103,264

120,826

Total liabilities

137,882

143,856

157,003

176,683

202,863

Common stock

13,226

13,226

13,226

13,226

13,226

Shareholders’ equity

180,420

203,952

228,666

245,228

259,339

Total assets

362,438

399,174

437,468

477,587

513,801

(Millions of Yen)

2022/03

2023/03

2024/03

2025/03

2026/03

Cash dividends

7,315

7,512

5,662

6,052

5,979

Capital expenditures

16,213

14,165

21,915

20,783

24,500

Depreciation

8,425

9,118

9,999

10,347

12,225

Research and development expenses

6,484

8,949

8,725

7,309

7,247

Cash flows from operating activities

16,376

45,478

29,178

16,155

17,318

Cash flows from investing activities

▲10,399

▲10,474

▲19,993

▲41,562

▲15,341

Cash flows from financing activities

4,133

▲22,215

▲13,448

6,548

▲9,307

Cash and cash equivalents at end of the year

75,729

91,785

90,184

75,280

69,125